These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31169739)

  • 41. High incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National antiretroviral therapy programme between 2011 and 2015.
    Mupfumi L; Moyo S; Shin SS; Wang Q; Zetola N; Molebatsi K; Nnawa J; Kgwaadira BT; Bewlay L; Chebani T; Iketleng T; Mogashoa T; Makhema J; Musonda RM; Essex M; Kasvosve I; Gaseitsiwe S
    AIDS; 2019 Dec; 33(15):2415-2422. PubMed ID: 31764106
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiretroviral therapy initiation within seven days of enrolment: outcomes and time to undetectable viral load among children at an urban HIV clinic in Uganda.
    Ssebunya R; Wanyenze RK; Lukolyo H; Mutto M; Kisitu G; Amuge P; Maganda A; Kekitiinwa A
    BMC Infect Dis; 2017 Jun; 17(1):439. PubMed ID: 28629459
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Virologic response of treatment experienced HIV-infected Ugandan children and adolescents on NNRTI based first-line regimen, previously monitored without viral load.
    Kibalama Ssemambo P; Nalubega-Mboowa MG; Owora A; Serunjogi R; Kironde S; Nakabuye S; Ssozi F; Nannyonga M; Musoke P; Barlow-Mosha L
    BMC Pediatr; 2021 Mar; 21(1):139. PubMed ID: 33752636
    [TBL] [Abstract][Full Text] [Related]  

  • 44. U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008.
    Althoff KN; Buchacz K; Hall HI; Zhang J; Hanna DB; Rebeiro P; Gange SJ; Moore RD; Kitahata MM; Gebo KA; Martin J; Justice AC; Horberg MA; Hogg RS; Sterling TR; Cescon A; Klein MB; Thorne JE; Crane HM; Mugavero MJ; Napravnik S; Kirk GD; Jacobson LP; Brooks JT;
    Ann Intern Med; 2012 Sep; 157(5):325-35. PubMed ID: 22944874
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Linkage and retention in care and the time to HIV viral suppression and viral rebound - New York City.
    Robertson M; Laraque F; Mavronicolas H; Braunstein S; Torian L
    AIDS Care; 2015; 27(2):260-7. PubMed ID: 25244545
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HIV-associated morbidity and mortality in a setting of high ART coverage: prospective surveillance results from a district hospital in Botswana.
    Barak T; Neo DT; Tapela N; Mophuthegi P; Zash R; Kalenga K; Perry ME; Malane M; Makhema J; Lockman S; Shapiro R
    J Int AIDS Soc; 2019 Dec; 22(12):e25428. PubMed ID: 31850683
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High levels of antiretroviral use and viral suppression among persons in HIV care in the United States, 2010.
    Dombrowski JC; Kitahata MM; Van Rompaey SE; Crane HM; Mugavero MJ; Eron JJ; Boswell SL; Rodriguez B; Mathews WC; Martin JN; Moore RD; Golden MR
    J Acquir Immune Defic Syndr; 2013 Jul; 63(3):299-306. PubMed ID: 23572013
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load.
    Phillips AN; Staszewski S; Weber R; Kirk O; Francioli P; Miller V; Vernazza P; Lundgren JD; Ledergerber B; ; ;
    JAMA; 2001 Nov; 286(20):2560-7. PubMed ID: 11722270
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HIV treatment outcomes following antiretroviral therapy initiation and monitoring: A workplace program in Papua, Indonesia.
    Limmade Y; Fransisca L; Rodriguez-Fernandez R; Bangs MJ; Rothe C
    PLoS One; 2019; 14(2):e0212432. PubMed ID: 30802257
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictors of mortality in adults on treatment for human immunodeficiency virus-associated tuberculosis in Botswana: A retrospective cohort study.
    Muyaya LM; Young T; Loveday M
    Medicine (Baltimore); 2018 Apr; 97(16):e0486. PubMed ID: 29668628
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiretroviral treatment outcomes among foreign-born and Aboriginal peoples living with HIV/AIDS in northern Alberta.
    Lefebvre ME; Hughes CA; Yasui Y; Saunders LD; Houston S
    Can J Public Health; 2014 Jul; 105(4):e251-7. PubMed ID: 25166126
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa.
    Boender TS; Hoenderboom BM; Sigaloff KC; Hamers RL; Wellington M; Shamu T; Siwale M; Labib Maksimos EE; Nankya I; Kityo CM; Adeyemo TA; Akanmu AS; Mandaliya K; Botes ME; Ondoa P; Rinke de Wit TF
    Clin Infect Dis; 2015 Dec; 61(11):1749-58. PubMed ID: 26240203
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HIV and the growing health burden from noncommunicable diseases in Botswana: modelling study.
    Haacker M; Bärnighausen T; Atun R
    J Glob Health; 2019 Jun; 9(1):010428. PubMed ID: 31293781
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adolescent HIV treatment in South Africa's national HIV programme: a retrospective cohort study.
    Maskew M; Bor J; MacLeod W; Carmona S; Sherman GG; Fox MP
    Lancet HIV; 2019 Nov; 6(11):e760-e768. PubMed ID: 31585836
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Twelve-year mortality in adults initiating antiretroviral therapy in South Africa.
    Cornell M; Johnson LF; Wood R; Tanser F; Fox MP; Prozesky H; Schomaker M; Egger M; Davies MA; Boulle A;
    J Int AIDS Soc; 2017 Sep; 20(1):21902. PubMed ID: 28953328
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age.
    Penazzato M; Prendergast A; Tierney J; Cotton M; Gibb D
    Cochrane Database Syst Rev; 2012 Jul; (7):CD004772. PubMed ID: 22786492
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa.
    Okomo U; Togun T; Oko F; Peterson K; Townend J; Peterson I; Jaye A
    BMC Pediatr; 2012 Jul; 12():95. PubMed ID: 22770231
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Access to antiretroviral therapy and survival in eastern Europe and central Asia: a case study in Armenia.
    Mallitt KA; Grigoryan SR; Papoyan AS; Wand HC; Wilson DP
    J Int AIDS Soc; 2014; 17(1):18795. PubMed ID: 25095830
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictors of first-line antiretroviral therapy failure among adults and adolescents living with HIV/AIDS in a large prevention and treatment program in Nigeria.
    Ndembi N; Murtala-Ibrahim F; Tola M; Jumare J; Aliyu A; Alabi P; Mensah C; Abimiku A; Quiñones-Mateu ME; Crowell TA; Rhee SY; Shafer RW; Gupta R; Blattner W; Charurat ME; Dakum P
    AIDS Res Ther; 2020 Nov; 17(1):64. PubMed ID: 33143751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Migration in Namibia and its association with HIV acquisition and treatment outcomes.
    Low A; Sachathep K; Rutherford G; Nitschke AM; Wolkon A; Banda K; Miller LA; Solmo C; Jackson K; Patel H; McCracken S; Findley S; Mutenda N
    PLoS One; 2021; 16(9):e0256865. PubMed ID: 34473757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.